The long term potential for VLA is still great, but you are probably right that the SP will fluctuate around this level until there is further clinical trial info.
I've sold 30% of my holdings for the time being. However I am holding the rest because there is always the possibility of other news, eg takeover; commercial partnerships etc. That could be a real gamechanger.